home / stock / ctmx / ctmx quote
Last: | $1.895 |
---|---|
Change Percent: | 0.26% |
Open: | $1.91 |
Close: | $1.89 |
High: | $1.93 |
Low: | $1.85 |
Volume: | 815,867 |
Last Trade Date Time: | 05/20/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.895 | $1.91 | $1.89 | $1.93 | $1.85 | 815,867 | 05-20-2024 |
$1.89 | $1.95 | $1.89 | $1.97 | $1.85 | 3,510,462 | 05-17-2024 |
$2 | $1.98 | $2 | $2.01 | $1.93 | 3,288,698 | 05-16-2024 |
$1.96 | $1.93 | $1.96 | $2.01 | $1.93 | 3,893,558 | 05-15-2024 |
$1.94 | $1.91 | $1.94 | $2.01 | $1.8607 | 4,544,277 | 05-14-2024 |
$1.89 | $1.95 | $1.89 | $2.01 | $1.88 | 6,114,521 | 05-13-2024 |
$1.98 | $2.03 | $1.98 | $2.05 | $1.85 | 12,154,821 | 05-10-2024 |
$2.04 | $2.722 | $2.04 | $2.8098 | $2.01 | 41,562,499 | 05-09-2024 |
$4.19 | $4.11 | $4.19 | $4.205 | $3.79 | 16,427,811 | 05-08-2024 |
$4.07 | $4.49 | $4.07 | $4.49 | $4.07 | 4,440,551 | 05-07-2024 |
$4.37 | $4.89 | $4.37 | $4.94 | $4.27 | 5,051,530 | 05-06-2024 |
$4.43 | $4.62 | $4.43 | $5.06 | $4.43 | 11,087,858 | 05-03-2024 |
$4.5 | $4.4 | $4.5 | $4.74 | $4.07 | 15,831,510 | 05-02-2024 |
$5.13 | $3.25 | $5.13 | $5.85 | $2.78 | 203,667,315 | 05-01-2024 |
$1.63 | $1.63 | $1.63 | $1.66 | $1.59 | 381,991 | 04-30-2024 |
$1.61 | $1.6 | $1.61 | $1.65 | $1.58 | 399,614 | 04-29-2024 |
$1.59 | $1.6 | $1.59 | $1.65 | $1.59 | 249,227 | 04-26-2024 |
$1.6 | $1.61 | $1.6 | $1.64 | $1.58 | 286,317 | 04-25-2024 |
$1.63 | $1.68 | $1.63 | $1.7 | $1.62 | 279,180 | 04-24-2024 |
$1.68 | $1.67 | $1.68 | $1.73 | $1.64 | 289,921 | 04-23-2024 |
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
Wednesday, CytomX Therapeutics Inc (NASDAQ:CTMX) released initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, d...
U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping over 200 points on Thursday. The Dow traded up 0.63% to 39,30...
Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results. Duol...